Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 KCNH2 (hERG) Mutations and Identifying New Patients

Significant advances in our understanding of the molecular mechanisms that cause congenital long QT syndrome (LQTS) have been made. A wide variety of experimental approaches, including heterologous expression of mutant ion channel proteins and the use of inducible pluripotent stem cell-derived cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ono, Makoto, Burgess, Don E., Schroder, Elizabeth A., Elayi, Claude S., Anderson, Corey L., January, Craig T., Sun, Bin, Immadisetty, Kalyan, Kekenes-Huskey, Peter M., Delisle, Brian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464307/
https://www.ncbi.nlm.nih.gov/pubmed/32759882
http://dx.doi.org/10.3390/biom10081144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464307/
https://www.ncbi.nlm.nih.gov/pubmed/32759882
http://dx.doi.org/10.3390/biom10081144

Ejemplares similares